Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
Jeremy Edwards
Advertisement
Articles by Jeremy Edwards
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Latest Updated Articles
Rare Disease Patients Overlooked During COVIDJune 7th 2021
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
3
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
4
2026 DIA Global Annual Meeting: Stacy Hurt of Parexel on Federated AI, the Patient Voice, and Accountability for Patient Needs
5